Intensive Care Therapy of Covid-19 Disease in Germany

Intensive Care Therapy of Covid-19 Disease in Germany an Multi-center Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04455451

Enrollment

2054

Registered

2020-07-02

Start date

2020-08-06

Completion date

2021-09-30

Last updated

2022-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, COVID

Brief summary

Multi-center retrospective and prospective observational study of Covid-19 patients with severe or critical illness treated on a German ICU

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age above 18 years * Covid-19 disease (positive SARS-CoV-2 PCR)

Exclusion criteria

-none

Design outcomes

Primary

Measure	Time frame	Description
Mortality	up to 150 days	ICU Mortality of patients

Secondary

Measure	Time frame	Description
ICU length of stay	up to 150 days	Intensive care unit length of stay

Countries

Germany

Outcome results